Mork Capital Management’s Cardinal Health CAH Stock Holding History

Mork Capital Management’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-19,550	Closed	-$1.5M	–	118
2022 Q4	$1.5M	Hold	19,550	–	–	1.15%	17
2022 Q3	$1.3M	Hold	19,550	–	–	1.28%	23
2022 Q2	$1.02M	Hold	19,550	–	–	0.94%	44
2022 Q1	$1.11M	Hold	19,550	–	–	1%	42
2021 Q4	$1.01M	Buy	19,550 +850	+5%	+$41.7K	0.68%	97
2021 Q3	$925K	Hold	18,700	–	–	0.79%	76
2021 Q2	$1.07M	Hold	18,700	–	–	0.77%	72
2021 Q1	$1.14M	Sell	18,700 -700	-4%	-$38.6K	0.87%	63
2020 Q4	$1.04M	Hold	19,400	–	–	0.76%	55
2020 Q3	$911K	Hold	19,400	–	–	1%	48
2020 Q2	$1.01M	Hold	19,400	–	–	1.19%	28
2020 Q1	$930K	Hold	19,400	–	–	1.27%	24
2019 Q4	$981K	Buy	19,400 +2,300	+13%	+$119K	0.7%	79
2019 Q3	$807K	Hold	17,100	–	–	0.74%	78
2019 Q2	$805K	Hold	17,100	–	–	0.75%	78
2019 Q1	$823K	Hold	17,100	–	–	0.77%	72
2018 Q4	$763K	Buy	17,100 +1,000	+6%	+$52.1K	0.71%	71
2018 Q3	$869K	Hold	16,100	–	–	0.7%	80
2018 Q2	$786K	Hold	16,100	–	–	0.69%	86
2018 Q1	$1.01M	Hold	16,100	–	–	0.97%	46
2017 Q4	$986K	Buy	+16,100	New	+$995K	0.66%	93

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mork Capital Management's CAH Position: Q1 2023 in Review

Mork Capital Management sold out of Cardinal Health (CAH) in Q1 2023, closing a stake of 19,550 shares — an estimated $1.5M sold.

Mork Capital Management first reported a position in CAH in Q4 2017 and held it in 21 quarters. The position peaked at $1.5M in Q4 2022. 908 funds tracked by Wall St. Rank hold CAH as of Q1 2023.

Mork Capital Management reported no remaining Cardinal Health position as of Q1 2023 after selling out during the quarter.
Mork Capital Management sold 19,550 Cardinal Health shares in Q1 2023, an estimated $1.5M.
Mork Capital Management first reported a position in Cardinal Health in Q4 2017 and held it in 21 quarters.
Mork Capital Management's Cardinal Health position peaked at $1.5M in Q4 2022.
908 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2023.

Based on Mork Capital Management's 13F filing for Q1 2023, filed 12 May 2023.